Evidence map›Paper›PMID 35281861›Full record

ArticleJournal of Cancer2022

Novel Insights into Pediatric Acute Lymphoblastic Leukemia Ophthalmic Relapses from a Nationwide Cohort Study.

Solenne Le Louet, Véronique Icart, Marion Strullu, Arnaud Petit, Claire Freycon, Pascale Blouin, Jill Serre, Nicolas Rama, Yves Reguerre, Christophe Piguet and 13 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 20 institutions in 2 countries.

Solenne Le LouetInstitute of Pediatric Hematology and Oncology, Hospices Civils de Lyon, University-Lyon1, Lyon, France.
Véronique IcartDepartment of Pediatric Ophtalmology, Hopital Nord Ouest de Villefranche sur Saône, Gleize, France.
Marion StrulluDepartment of Pediatric Hematology, Hôpital Robert-Debré, Paris, France.
Arnaud PetitDepartment of Pediatric Hematology, Hôpital Armand-Trousseau, Paris, France.
Claire FreyconDepartment of Pediatric Hematology, CHU Grenoble Alpes, Grenoble, France.
Pascale BlouinDepartment of Pediatric Hematology, CHRU de Tours, Tours, France.
Jill SerreDepartment of Pediatric Hematology, CHRU de Tours, Tours, France.
Nicolas RamaApoptosis, Cancer and Development Laboratory - Center of Research of Cancerology of Lyon, INSERM U1052-CNRS UMR5286, Lyon, France.
Yves ReguerreDepartment of Pediatric Hematology, Centre hospitalier Félix-Guyon, Saint Denis de La Réunion, France.
Christophe PiguetDepartment of Pediatric Hematology, CHU de Limoges, Limoges, France.
Marlène PasquetDepartment of Pediatric Hematology, CHU de Toulouse, Toulouse, France.
Audrey DavidDepartment of Pediatric Hematology, CHU de Saint Etienne, Saint Etienne, France.
Pauline SimonDepartment of Pediatric Hematology, CHU de Besançon, Besançon, France.
Marilyne PoireeDepartment of Pediatric Hematology, CHU de Nice, Nice, France.
Liana CarausuDepartment of Pediatric Hematology, CHU de Brest, Brest, France.
Fanny RiallandDepartment of Pediatric Hematology, CHU de Nantes, Nantes, France.
Wadih AbouchahlaDepartment of Pediatric Hematology, CHU de Lille, Lille, France.
Paul SaultierDepartment of Pediatric Hematology, Hôpital de la Timone, Marseille, France.
Stéphane DucassouDepartment of Pediatric Hematology, CHU de Bordeaux, Bordeaux, France.
Julie ValdugaDepartment of Pediatric Hematology, CHRU de Nancy, Nancy, France.
André BaruchelDepartment of Pediatric Hematology, Hôpital Robert-Debré, Paris, France.
Yves BertrandInstitute of Pediatric Hematology and Oncology, Hospices Civils de Lyon, University-Lyon1, Lyon, France.
Carine DomenechInstitute of Pediatric Hematology and Oncology, Hospices Civils de Lyon, University-Lyon1, Lyon, France.
Centre Hospitalier Universitaire de Tours · FRHôpital Robert-Debré · FRUniversité Claude Bernard Lyon 1 · FRCentre de Recherche en Automatique de Nancy · FRCentre Hospitalier Régional Universitaire de Brest · FRCentre Hospitalier Universitaire de Besançon · FRCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Lille · FRCentre Hospitalier Universitaire de Limoges · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire de Toulouse · FRCentre National de la Recherche Scientifique · FRCommunication Bactérienne et Stratégie Anti-infectieusesÉcologie Marine Tropicale des Océans Pacifique et Indien · REHôpital de la Timone · FRHôpital l'Archet · FRHôpital Nord · FRHôpital Pellegrin · FRInserm · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ten to fifteen percent of children with acute lymphoblastic leukemia (ALL) relapse following treatment. Of these, less than 2% display ophthalmic relapses, which owing to their scarcity, are largely undocumented, leaving clinicians with few diagnostic and therapeutic recommendations, despite serious functional sequelae. We conducted a French multicenter retrospective study to collect all clinical, radiological, biological, and therapeutic data, and outcomes for children with ALL ophthalmic relapses. From 2000 to 2020, 20 ophthalmic relapses occurring after first-line therapy performed before January 1

Indexed as

ALLChildhoodophthalmic relapse

Identifiers

PMID35281861
PMCPMC8899370
OpenAlexW4210886605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.